logo

For the Inventor, By the Inventor

Charlottesville, VA, United States of America

Diffusion Pharmaceuticals LLC


USPTO Granted Patents = 18

% Expired Patents = 38.9



Trademarks = 2

Forward Citations = 104

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal John L Gainer (18 out of 25 patents)

silverMedal Raymond C Grabiak (6 out of 24 patents)

bronzeMedal Marc Lanz (3 out of 4 patents)

4.  Robert H Murray (3 out of 32 patents)


18 patents:

1. 11491129 - Oral formulations of bipolar trans carotenoids (2022-11-08),
2. 11278621 - Trans carotenoids, their synthesis, formulation and uses (2022-03-22),
3. 11185523 - Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer (2021-11-30),
4. 11147859 - Diffusion enhancing compounds and their use alone or with thrombolytics (2021-10-19),
5. 10130689 - Diffusion enhancing compounds and their use alone or with thrombolytics (2018-11-20),
6. 10016384 - Oral formulations of bipolar trans carotenoids (2018-07-10),
7. 9950067 - Trans carotenoids, their synthesis, formulation and uses (2018-04-24),
8. 9604899 - Bipolar trans carotenoid salts and their uses (2017-03-28),
9. 8974822 - Oral formulations of bipolar trans carotenoids (2015-03-10),
10. 8901174 - Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease (2014-12-02),
11. 8293804 - Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease (2012-10-23),
12. 8269027 - Bipolar trans carotenoid salts and their uses (2012-09-18),
13. 8206751 - Class of therapeutics that enhance small molecule diffusion (2012-06-26),
14. 8030350 - Trans carotenoids, their synthesis, formulation and uses (2011-10-04),
15. 8017653 - Bipolar trans carotenoid salts and their uses (2011-09-13),
Diffusion Pharmaceuticals LLC is a clinical-stage biotechnology company that focuses on developing novel small molecules to enhance the effectiveness of standard cancer treatments. Their lead investigational drug, trans sodium crocetinate (TSC), is being studied for its potential to increase the oxygenation of tumor tissue, improving the response of radiation therapy and chemotherapy. Diffusion Pharmaceuticals is dedicated to transforming the lives of patients battling cancer through innovative therapies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Diffusion Pharmaceuticals LLC
18 Patents

#11 in Charlottesville, VA

#300 in Virginia

#17,913 in US

#34,099 in the World

Charlottesville, VA (US)
Charlottesville, VA, United States of America

Diffusion Pharmaceuticals LLC

Forward Citations = 104

4 inventors:

goldMedal John L Gainer (18 out of 25 patents)

silverMedal Raymond C Grabiak (6 out of 24 patents)

bronzeMedal Marc Lanz (3 out of 4 patents)

4.  Robert H Murray (3 out of 32 patents)

Please report any incorrect information to [email protected]
Loading…